Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H, Osanai T, Ishizaka H, Hanada H, Kamada T, Onodera H, Fujita N, Sasaki S, Matsunaga T, Okumura K. Ono H, et al. Among authors: osanai t. Am Heart J. 2004 Oct;148(4):E15. doi: 10.1016/j.ahj.2004.05.014. Am Heart J. 2004. PMID: 15459610 Clinical Trial.
Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose tolerance.
Yokoyama J, Sutoh N, Higuma T, Horiuchi D, Katoh C, Yokota T, Echizen T, Sasaki S, Hanada H, Osanai T, Okumura K. Yokoyama J, et al. Among authors: osanai t. Heart Vessels. 2007 May;22(3):146-51. doi: 10.1007/s00380-006-0951-z. Epub 2007 May 21. Heart Vessels. 2007. PMID: 17533517
Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.
Fujiwara T, Matsunaga T, Kameda K, Abe N, Ono H, Higuma T, Yokoyama J, Hanada H, Osanai T, Okumura K. Fujiwara T, et al. Among authors: osanai t. Heart Vessels. 2007 Sep;22(5):303-9. doi: 10.1007/s00380-007-0975-z. Epub 2007 Sep 20. Heart Vessels. 2007. PMID: 17879021 Clinical Trial.
Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Hanada K, Higuma T, Nishizaki F, Sukekawa T, Yokota T, Yamada M, Saito S, Kushibiki M, Oikawa K, Abe N, Tomita H, Osanai T, Okumura K. Hanada K, et al. Among authors: osanai t. Circ J. 2012;76(2):439-45. doi: 10.1253/circj.cj-11-0947. Epub 2011 Dec 10. Circ J. 2012. PMID: 22156314 Free article. Clinical Trial.
432 results